GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease

Senkevich, K., Zorca, C. E., Dworkind, A., Rudakou, U., Somerville, E., Yu, E., Ermolaev, A., Nikanorova, D., Ahmad, J., Ruskey, J. A., Asayesh, F., Spiegelman, D., Fahn, S., Waters, C., Monchi, O., Dauvilliers, Y., Dupré, N., Greenbaum, L., Hassin-Baer, S., … Gan-Or, Z. (2022). GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease. Brain, 146(5), 1859–1872. https://doi.org/10.1093/brain/awac413
Authors:
Konstantin Senkevich
Cornelia E Zorca
Aliza Dworkind
Uladzislau Rudakou
Emma Somerville
Eric Yu
Alexey Ermolaev
Daria Nikanorova
Jamil Ahmad
Jennifer A Ruskey
Farnaz Asayesh
Dan Spiegelman
Stanley Fahn
Cheryl Waters
Oury Monchi
Yves Dauvilliers
Nicolas Dupré
Lior Greenbaum
Sharon Hassin-Baer
Francis P Grenn
Ming Sum Ruby Chiang
S Pablo Sardi
Benoît Vanderperre
Cornelis Blauwendraat
Jean-François Trempe
Edward A Fon
Thomas M Durcan
Roy N Alcalay
Ziv Gan-Or
Affiliated Authors:
Stanley Fahn
Cheryl Waters
Roy N Alcalay
Columbia Affiliation:
Subjects:
Parkinson Disease (MeSH)
Author Keywords:
galactosylceramidase
gba1
genome-wide association study
parkinson’s disease
sphingolipid pathway
elink
Publication Type:
Article
Unique ID:
10.1093/brain/awac413
PMID:
36370000
DOI:
10.1093/brain/awac413
Journal:
Brain
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: